Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.215 USD | -1.02% | -9.92% | +13.21% |
Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
Apr. 18 | Verastem Oncology Announces Executive Changes | CI |
Business Summary
Number of employees: 73
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dan Paterson
CEO | Chief Executive Officer | 63 | 10-12-31 |
Daniel Calkins
DFI | Director of Finance/CFO | 37 | 18-11-30 |
Jonathan Pachter
CTO | Chief Tech/Sci/R&D Officer | 66 | 11-06-30 |
Brian Stuglik
BRD | Director/Board Member | 64 | 17-09-01 |
Michael Crowther
PRN | Corporate Officer/Principal | - | 23-10-25 |
Corporate Officer/Principal | 67 | 17-01-18 | |
Cathy Carew
PRN | Corporate Officer/Principal | - | - |
David Mitchell
LAW | General Counsel | 67 | 23-10-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 67 | 17-05-02 |
John Johnson
BRD | Director/Board Member | 66 | 20-04-22 |
Michael Kauffman
CHM | Chairman | 60 | 12-11-25 |
Dan Paterson
CEO | Chief Executive Officer | 63 | 10-12-31 |
Paul Bunn
BRD | Director/Board Member | 79 | 21-06-23 |
Anil Kapur
BRD | Director/Board Member | 54 | 22-10-19 |
Robert Gagnon
BRD | Director/Board Member | 49 | 22-12-12 |
Karin Tollefson
BRD | Director/Board Member | 57 | 23-05-14 |
Brian Stuglik
BRD | Director/Board Member | 64 | 17-09-01 |
Director/Board Member | 57 | 21-11-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,307,669 | 25,163,000 ( 99.43 %) | 0 | 99.43 % |
Stock B | 0 | 1,200,000 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.21% | 236M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- VSTM Stock
- Company Verastem, Inc.